Experience of using secukinumab in treatment of severe refractory psoriasis: A clinical case.

0Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

In this article we present a clinical case of a patient with severe psoriasis. We assessed efficacy and safety of secukinumab therapy with 88 weeks follow-up.

Cite

CITATION STYLE

APA

Kungurov, N. V., Keniksfest, Y. V., Kokhan, M. M., Syrneva, T. A., & Grishaeva, E. V. (2019). Experience of using secukinumab in treatment of severe refractory psoriasis: A clinical case. Russian Open Medical Journal, 8(2). https://doi.org/10.15275/rusomj.2019.0209

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free